Fatty liver in a case with heterozygous familial hypobetalipoproteinemia

American Journal of Gastroenterology

Volumn 92, Issue 2, 1997, Pages 339-342

  Ogata, Hisanobu ^b   Akagi, Kimihiro ^a   Baba, Mitsuo ^b   Nagamatsu, Akio ^b   Suzuki, Norihisa ^b   Nomiyama, Kensuke ^b   Fujishima, Masatoshi ^b  

^a Saiseikai Yahata Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; APOLIPOPROTEIN B; CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE REPORT; ECHOGRAPHY; FAMILY STUDY; FATTY LIVER; HETEROZYGOSITY; HUMAN; HYPOBETALIPOPROTEINEMIA; MALE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS; FATTY LIVER; FEMALE; HETEROZYGOTE; HUMANS; HYPOBETALIPOPROTEINEMIAS; LIPIDS; LIVER; MALE; MIDDLE AGED;

EID: 0031058121     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Young SG. Recent progress in understanding apolipoprotein B. Circulation 1990;82:1574-94.
2. Malloy MJ, Kane JP. Hypolipidemia. Med Clin North Am 1982;66: 469-84.
3. Kudo A, Tanaka N, Oogaki S, et al. Hypobetalipoproteinemia with abnormal prebetalipoprotein. J Neurol Sci 1977;31:411-9.
4. Wishingrad M, Paaso B, Garcia G. Fatty liver due to heterozygous hypobetalipoproteinemia. Am J Gastroenterol 1994;89:1106-7.
5. Skeggs LT, Hochstrasser H. Multiple automatic sequential analysis. Clin Chem 1964;10:918-36.
6. Overby LR, Ling CM. Radioimmune assay for anti-core as evidence for exposure to hepatitis B virus. Rush Presbyt St Lukes Med Bull 1976;15:83-92.
7. Leon P, Lopez JA, Domingo C, et al. Evaluation of laboratory assays for screening antibody to hepatitis C virus. Transfusion 1993;33:268-70.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Rifai N, Silverman LM. Immunoturbidimetric techniques for quantifying apolipoproteins C II and C III. Clin Chem 1986;32:1969-72.
10. Rifai N, Silverman LM. A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta 1987;163:207-13.
11. Stunkard AJ, Sorensen TIA, Hanis C, et al. An adoption study of human obesity. N Engl J Med 1986;314:193-201.
12. Linton MF, Farese RV, Young SG. Familial hypobetalipoproteinemia. J Lipid Res 1993:34:521-41.
13. Malmendier CL, Delcroix C, Lontie JF, et al. Apolipoprotein C-II and C-III metabolism in a kindred of familial hypobetalipoproteinemia. Metabolism 1991;40:45-50.
14. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12:1106-10.
15. Nanji AA, Tsukamoto H, French SW. Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease. Exp Mol Patho 1989;51:141-8.
16. Buchem FSP, Pol G, Gier J. Congenital β-lipoprotein deficiency. Am J Med 1966;40:794-804.
17. Harano Y, Kojima H, Nakano T, et al. Homozygous hypobetalipoproteinemia with spared chylomicron formation. Metabolism 1989;38: 1-7.
18. Herbert PN, Hyams JS, Bernier DN, et al. Apolipoprotein B-100 deficiency: Intestinal steatosis despite apolipoprotein B-48 synthesis. J Clin Invest 1985;76:403-12.